Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126337662 | 12633766 | 2 | F | 20160708 | 20160818 | 20160809 | 20160829 | EXP | FR-PFIZER INC-2016365712 | PFIZER | 60.00 | YR | M | Y | 0.00000 | 20160829 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126337662 | 12633766 | 1 | PS | Carboplatine Hospira | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 750 MG, CYCLIC | Y | 76517 | 750 | MG | |||||||
| 126337662 | 12633766 | 2 | SS | Carboplatine Hospira | CARBOPLATIN | 1 | 720 MG ON DAY 2 | Y | 76517 | 720 | MG | ||||||||
| 126337662 | 12633766 | 3 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 10400 MG, CYCLIC | Y | 6D282E6 | 0 | 10400 | MG | ||||||
| 126337662 | 12633766 | 4 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | 10400 MG ON DAY 2 | Y | 0 | 10400 | MG | ||||||||
| 126337662 | 12633766 | 5 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 780 MG, CYCLIC | Y | 0 | 780 | MG | |||||||
| 126337662 | 12633766 | 6 | SS | MABTHERA | RITUXIMAB | 1 | 780 MG ON DAY 1 | Y | 0 | 780 | MG | ||||||||
| 126337662 | 12633766 | 7 | SS | ETOPOSIDE MYLAN | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 600 MG (200 MG X3), CYCLIC | Y | 0 | 600 | MG | |||||||
| 126337662 | 12633766 | 8 | SS | ETOPOSIDE MYLAN | ETOPOSIDE | 1 | 200 MG ON DAY 1 AND 2 | Y | 0 | 200 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126337662 | 12633766 | 1 | Lymphoma |
| 126337662 | 12633766 | 3 | Lymphoma |
| 126337662 | 12633766 | 5 | Lymphoma |
| 126337662 | 12633766 | 7 | Lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126337662 | 12633766 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126337662 | 12633766 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126337662 | 12633766 | 1 | 20160706 | 20160706 | 0 | |
| 126337662 | 12633766 | 3 | 20160706 | 20160706 | 0 | |
| 126337662 | 12633766 | 5 | 20160706 | 20160706 | 0 | |
| 126337662 | 12633766 | 7 | 20160706 | 20160706 | 0 |